翻訳と辞書 |
Orexigen Therapeutics : ウィキペディア英語版 | Orexigen Therapeutics
Orexigen Therapeutics is a public American pharmaceutical company focused on development of treatments for obesity.〔 The company is based in La Jolla, California and was established by Eckard Weber in 2002.〔 As a public company, Orexigen is traded on the NASDAQ exchange under the stock symbol OREX.〔 The company has a single product, Contrave, approved for use in the United States in 2014.〔 The launch of Contrave was conducted through a sales force of 900.〔 Observation of the market performance of Qsymia and Belviq suggest overall low demand for pharmaceutical obesity therapies, calling into question earnings potential for Orexigen's offering.〔 ==References==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Orexigen Therapeutics」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|